JP2021533783A5 - - Google Patents

Info

Publication number
JP2021533783A5
JP2021533783A5 JP2021507883A JP2021507883A JP2021533783A5 JP 2021533783 A5 JP2021533783 A5 JP 2021533783A5 JP 2021507883 A JP2021507883 A JP 2021507883A JP 2021507883 A JP2021507883 A JP 2021507883A JP 2021533783 A5 JP2021533783 A5 JP 2021533783A5
Authority
JP
Japan
Prior art keywords
seq
purified
composition
antigen
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021507883A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021533783A (ja
JP7570316B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2019/051120 external-priority patent/WO2020034042A1/en
Publication of JP2021533783A publication Critical patent/JP2021533783A/ja
Publication of JP2021533783A5 publication Critical patent/JP2021533783A5/ja
Priority to JP2024111653A priority Critical patent/JP2024163994A/ja
Application granted granted Critical
Publication of JP7570316B2 publication Critical patent/JP7570316B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021507883A 2018-08-17 2019-08-16 糖鎖抗原除去のための酵素組成物、それに関連する方法、使用、装置およびシステム Active JP7570316B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024111653A JP2024163994A (ja) 2018-08-17 2024-07-11 糖鎖抗原除去のための酵素組成物、それに関連する方法、使用、装置およびシステム

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862719272P 2018-08-17 2018-08-17
US62/719,272 2018-08-17
PCT/CA2019/051120 WO2020034042A1 (en) 2018-08-17 2019-08-16 Enzymatic compositions for carbohydrate antigen cleavage, methods, uses, apparatuses and systems associated therewith

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024111653A Division JP2024163994A (ja) 2018-08-17 2024-07-11 糖鎖抗原除去のための酵素組成物、それに関連する方法、使用、装置およびシステム

Publications (3)

Publication Number Publication Date
JP2021533783A JP2021533783A (ja) 2021-12-09
JP2021533783A5 true JP2021533783A5 (enExample) 2022-08-23
JP7570316B2 JP7570316B2 (ja) 2024-10-21

Family

ID=69524510

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2021532503A Active JP7684216B2 (ja) 2018-08-17 2019-08-16 ドナー臓器における糖鎖抗原除去のための酵素組成物、それに関連する方法および使用
JP2021507883A Active JP7570316B2 (ja) 2018-08-17 2019-08-16 糖鎖抗原除去のための酵素組成物、それに関連する方法、使用、装置およびシステム
JP2024111653A Pending JP2024163994A (ja) 2018-08-17 2024-07-11 糖鎖抗原除去のための酵素組成物、それに関連する方法、使用、装置およびシステム
JP2025081746A Pending JP2025131609A (ja) 2018-08-17 2025-05-15 ドナー臓器における糖鎖抗原除去のための酵素組成物、それに関連する方法および使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021532503A Active JP7684216B2 (ja) 2018-08-17 2019-08-16 ドナー臓器における糖鎖抗原除去のための酵素組成物、それに関連する方法および使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2024111653A Pending JP2024163994A (ja) 2018-08-17 2024-07-11 糖鎖抗原除去のための酵素組成物、それに関連する方法、使用、装置およびシステム
JP2025081746A Pending JP2025131609A (ja) 2018-08-17 2025-05-15 ドナー臓器における糖鎖抗原除去のための酵素組成物、それに関連する方法および使用

Country Status (8)

Country Link
US (4) US20210324361A1 (enExample)
EP (2) EP3837370A4 (enExample)
JP (4) JP7684216B2 (enExample)
CN (4) CN112839512B (enExample)
AU (1) AU2019322933B2 (enExample)
BR (1) BR112021002899A2 (enExample)
CA (2) CA3109723A1 (enExample)
WO (2) WO2020034043A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116024183B (zh) * 2023-02-15 2023-10-31 中国农业科学院兰州兽医研究所 一种用于荧光染色的重组蓝舌病毒及其构建方法
WO2025213250A1 (en) * 2024-04-11 2025-10-16 The University Of British Columbia Enzymatic compositions for b antigen cleavage, methods, uses, apparatuses and systems associated therewith
JP2026057100A (ja) 2024-09-20 2026-04-02 トヨタ自動車株式会社 電気ユニット

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4609627A (en) * 1983-08-01 1986-09-02 New York Blood Center, Inc. Enzymatic conversion of certain sub-type A and AB erythrocytes
CA2272925A1 (en) * 1996-11-21 1998-05-28 Jack Goldstein Method for conversion of blood type
US7767415B2 (en) * 2001-09-25 2010-08-03 Velico Medical, Inc. Compositions and methods for modifying blood cell carbohydrates
WO2007053565A2 (en) 2005-10-31 2007-05-10 Zymequest, Inc. Novel a-galactosidases
WO2007100294A1 (en) * 2006-02-28 2007-09-07 Kurt Nilsson Material system for blood products
CA2697999C (en) * 2009-04-24 2013-04-30 Werner Hoelke A stabilized aqueous alpha-galactosidase composition and methods relating thereto
JP6336392B2 (ja) 2012-09-08 2018-06-06 株式会社オーガンテクノロジーズ 移植のための臓器又は組織の長期維持方法
CA2920293A1 (en) 2013-08-16 2015-02-19 Alexion Pharmaceuticals, Inc. Treatment of graft rejection by administering a complement inhibitor to an organ prior to transplant
CN107298699B (zh) * 2017-07-21 2020-09-11 天津大学 通过添加大分子拥挤试剂高效体外生物生产蛋白质的配方及方法
EP3962295A1 (en) * 2019-05-01 2022-03-09 The Procter & Gamble Company Probiotic bacterial strains that produce short chain fatty acids and compositions comprising same

Similar Documents

Publication Publication Date Title
ES3058149T3 (en) Reagents and methods for molecular barcoding of nucleic acids of single cells
Wong et al. Substrate recognition by ADAR1 and ADAR2.
JP2022023041A (ja) クロストリジウム・ヒストリチクム(clostridium histolyticum)酵素およびその使用のための方法
JP2021533783A5 (enExample)
JP2007537197A5 (enExample)
US5270176A (en) Method for the selective cleavage of fusion proteins with lysostaphin
Michaeli et al. Localization of antigenic determinants in the polypeptide chains of collagen
US20120270808A1 (en) Compositions and methods related to synchronous selection of homing peptides for multiple tissues by in vivo phage display
JP2020525003A (ja) 腎臓病治療のための免疫特権を有する生物活性腎細胞
EP0388466B1 (fr) ACIDE NUCLEIQUE CODANT POUR L'ENZYME DE CONVERSION DE L'ANGIOTENSINE (ECA) HUMAINE, ET SES APPLICATIONS, NOTAMMENT POUR LE DIAGNOSTIC $i(IN VITRO) DE L'HYPERTENSION ARTERIELLE
JPS60214897A (ja) タンパク質の製造法
TW201114467A (en) Method, agent, and kit for isolating nucleic acids
JPH1087508A (ja) アンギオゲニンの抑制剤
JP2021532838A5 (enExample)
Herrler et al. Haptoglobin expression and release by rabbit oviduct and endometrium, its localization in blastocyst extra-embryonic matrix and fluid during preimplantation time
CN118291587B (zh) 一种组合物及其在核酸纯化中的应用
CN116444674B (zh) 一种抗血管性血友病因子抗体及其应用
US11065280B2 (en) Hepatocytes with high regenerative capacity for liver repair
JPH07149654A (ja) アンギオゲニンの抑制剤
JPH03505530A (ja) プラスミノーゲン活性化因子の修飾
JP2024543469A (ja) 巨核球由来細胞外小胞のバイオマーカー
Inagami Purification of renin and prorenin.
JP2024523001A (ja) 新たなnrg1融合体、融合接合部及びそれらを検出するための方法
WO2021023123A1 (zh) 一种非特异性扩增天然短片段核酸的方法和试剂盒
JPH03505677A (ja) ヒト胎盤リボヌクレアーゼインヒビターをコードするdna配列を含むプラスミド